Patents by Inventor Xinmeng Mu

Xinmeng Mu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS FOR PD-1 AXIS BINDING ANTAGONIST THERAPY
    Publication number: 20230250173
    Abstract: The present disclosure describes therapies comprising a PD-1 axis binding antagonist, wherein a sample from the patient has been pre-determined to have certain biomarkers.
    Type: Application
    Filed: June 29, 2021
    Publication date: August 10, 2023
    Inventors: Keith Anthony Ching, Craig Davis, Xinmeng Mu, Shobha Potluri, Yan Qu, Shahram Salek-Ardakani, Graham Thomas, Ji Wen
  • PD-1 AXIS BINDING ANTAGONIST TO TREAT CANCER WITH GENETIC MUTATIONS IN SPECIFIC GENES
    Publication number: 20220241263
    Abstract: The present disclosure describes combination therapies comprising a PD-1 axis binding antagonist, wherein the cancer has been pre-determined to have one or more genetic mutations in one or more genes, to have certain gene expression profiles, and/or to have other biomarkers.
    Type: Application
    Filed: May 29, 2020
    Publication date: August 4, 2022
    Inventors: Marat Alimzhanov, Keith Anthony Ching, Alessandra Di Pietro, Xinmeng Mu, Paul Brian Robbins